References
- Ellis C N, Katz H I, Rex IH, Jr, et al. A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis. Clin Ther 1989; 11: 768–74
- Jegasothy B, Jacobson C, Levine N, et al. Clobetasol propionate versus fluocinonide creams in psoriasis and eczema. Int J Dermatol 1985; 24: 461–5
- Jegasothy BV. Clobetasol propionate ointment 0.05% versus diflorasone diacetate ointment 0.05% in moderate to severe psoriasis. Int J Dermatol 1990; 29: 729–30
- Savin R C, Stoughton R B, Cornell RC, et al. Comparative study of desoximetasone ointment 0.25% versus fluocinonide ointment 0.05% in patients with psoriasis. Clin Ther 1985; 8: 118–25
- Shupack J L, Jondreau L, Kenny C, et al. Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis. Dermatology 1993; 186: 129–32
- Giannotti B, Pimpinelli N. Topical corticosteroids: Which drug and when?. Drugs 1992; 44: 65–71
- Stoughton R B, Cornell RC. Review of superpotent topical corticosteroids. Semin Dermatol 1987; 6: 72–6
- Stoughton R B, Cornell RC. Topical corticosteroids in dermatology. Topical corticosteroid therapy: a novel approach to safer drugs., E Christophers, AM Kligman, E Schopf, et al. Raven Press, New York 1988; 1–12
- Cornell RC. Clinical trials of topical corticosteroids in psoriasis: correlations with the vasoconstrictor assay. Int J Dermatol 1992; 38–40, Suppl 1